WIPO trademark

ColHySilic

RegisteredWIPOClass 1Class 5

"ColHySilic" is a trademark owned by SISAF Ltd, filed at the WIPO on May 13, 2022. It is registered and covers classes 1 and 5.

View SISAF Ltd portfolioGet this data via the API
ColHySilic
Trademark as filed with the WIPO
Status
Registered
Filed
May 13, 2022
Registered
Not yet
Expires
May 13, 2032
Application no.
Not recorded
Registration no.
1704443
Office
WIPO
World Intellectual Property Organization
Mark type
Trademark
2 classes
Ownership

Who owns ColHySilic

The owner on file, matched to the company behind it. Every owner-name spelling for that company is grouped on its page.

Owner

SISAF Ltd

United Kingdom

19 trademarks in the portfolioView company

Representative

Evi T. Christou

Banner & Witcoff, Ltd.

Goods and services

What the mark covers

The products and services ColHySilic is filed for, grouped by Nice class.

  • Nanoparticle substances and nanoparticles for use in industry, science and research; silicon for use in industry, science and research; silicon nanoparticle materials for use in industry, science and research; porous silicon nanoparticle materials for use in industry, science and research; lipid nanoparticles for use in industry, science and research; silicon-lipid nanoparticles for use in industry, science and research; silicon-stabilised hybrid lipid nanoparticles for use in industry, science and research; silicon-stabilised lipid nanoparticles for use in industry, science and research; stabilised lipid nanoparticles for use in industry, science and research; chemical materials for carrying and delivery of chemical, biochemical and biological substances; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances; chemical materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals; chemical materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of pharmaceuticals in gene therapy; chemical materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; porous silicon nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-lipid nanoparticle materials for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-stabilised hybrid lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; silicon-stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; stabilised lipid nanoparticles for carrying and delivery of chemical, biochemical and biological substances for use in the manufacture of vaccines; chemical materials for stabilising of chemical, biochemical and biological substances; nanoparticle materials for stabilising of chemical, biochemical and biological substances; silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; porous silicon nanoparticle materials for stabilising of chemical, biochemical and biological substances; lipid nanoparticle materials for stabilising of chemical, biochemical and biological substances; silicon-lipid nanoparticle materials for stabilising of chemical, biochemical and biological substances; silicon-stabilised hybrid lipid nanoparticles for stabilising of chemical, biochemical and biological substances; silicon-stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances; stabilised lipid nanoparticles for stabilising of chemical, biochemical and biological substances; chemical materials for stabilising nucleic acids; nanoparticle materials for stabilising nucleic acids; silicon nanoparticle materials for stabilising nucleic acids; porous silicon nanoparticle materials for stabilising nucleic acids; lipid nanoparticle materials for stabilising nucleic acids; silicon-lipid nanoparticle materials for stabilising nucleic acids; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acids; silicon-stabilised lipid nanoparticles for stabilising nucleic acids; stabilised lipid nanoparticles for stabilising nucleic acids; chemical materials for stabilising nucleic acid-lipid complexes; nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon nanoparticle materials for stabilising nucleic acid-lipid complexes; porous silicon nanoparticle materials for stabilising of nucleic acid-lipid complexes; lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon-lipid nanoparticle materials for stabilising nucleic acid-lipid complexes; silicon-stabilised hybrid lipid nanoparticles for stabilising nucleic acid-lipid complexes; silicon-stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes; stabilised lipid nanoparticles for stabilising nucleic acid-lipid complexes.

  • Nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical purposes; silicon nanoparticle substances and silicon nanoparticle preparations for medical, veterinary and pharmaceutical purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparations for medical, veterinary and pharmaceutical purposes; lipid nanoparticle substances and lipid nanoparticle preparations for medical, veterinary and pharmaceutical purposes; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparations for medical, veterinary and pharmaceutical purposes; silicon-stabilised hybrid lipid nanoparticles for medical, veterinary and pharmaceutical purposes; silicon-stabilised lipid nanoparticles for medical, veterinary and pharmaceutical purposes; stabilised lipid nanoparticles for medical, veterinary and pharmaceutical purposes; nanoparticle substances and nanoparticle preparations for pharmaceutical, medical and veterinary diagnosis purposes; silicon nanoparticle substances and silicon nanoparticle preparations for pharmaceutical, medical and veterinary diagnosis purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparations for pharmaceutical, medical and veterinary diagnosis purposes; lipid nanoparticle substances and lipid nanoparticle preparations for pharmaceutical, medical and veterinary diagnosis purposes; silicon-lipid nanoparticle substances and silicon-lipid nanoparticle preparations for pharmaceutical, medical and veterinary diagnosis purposes; silicon-stabilised hybrid lipid nanoparticles for pharmaceutical, medical and veterinary diagnosis purposes; silicon-stabilised lipid nanoparticles for pharmaceutical, medical and veterinary diagnosis purposes; stabilised lipid nanoparticles for pharmaceutical, medical and veterinary diagnosis purposes; nanoparticle substances and nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; silicon nanoparticle substances and silicon nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; porous silicon nanoparticle substances and porous silicon nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; lipid nanoparticle substances and lipid nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; silicon-lipid nanoparticle substances and lipid nanoparticle preparations for medical, veterinary and pharmaceutical treatment purposes; silicon-stabilised hybrid lipid nanoparticles for medical, veterinary and pharmaceutical treatment purposes; silicon-stabilised lipid nanoparticles for medical, veterinary and pharmaceutical treatment purposes; stabilised lipid nanoparticles for medical, veterinary and pharmaceutical treatment purposes; pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; lipid nanoparticles being pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; silicon-lipid nanoparticles being pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; stabilised lipid nanoparticles being pharmaceutical preparations for carrying and delivery of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; lipid nanoparticles being pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; silicon-lipid nanoparticles being pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; stabilised lipid nanoparticles being pharmaceutical preparations for stabilising of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for stabilising nucleic acids; pharmaceutical nanoparticle preparations for stabilising nucleic acids; pharmaceutical silicon nanoparticle preparations for stabilising nucleic acids; pharmaceutical porous silicon nanoparticle preparations for stabilising nucleic acids; lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acids; silicon-lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acids; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acids; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acids; stabilised lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acids; pharmaceutical preparations for stabilising nucleic acid-lipid complexes; pharmaceutical nanoparticle preparations for stabilising nucleic acid-lipid complexes; pharmaceutical silicon nanoparticle preparations for stabilising nucleic acid-lipid complexes; pharmaceutical porous silicon nanoparticle preparations for stabilising nucleic acid-lipid complexes; lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acid-lipid complexes; silicon-lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acid-lipid complexes; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acid-lipid complexes; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acid-lipid complexes; stabilised lipid nanoparticles being pharmaceutical preparations for stabilising nucleic acid-lipid complexes; pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical porous silicon nanoparticle preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; lipid nanoparticle materials being pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; silicon-lipid nanoparticle materials being pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; stabilised lipid nanoparticles being pharmaceutical preparations for controlled release and onset of chemical, biochemical, biological and pharmaceutical substances; pharmaceutical preparations for controlled release and transfection of nucleic acids; pharmaceutical nanoparticle preparations for controlled release and transfection of nucleic acids; pharmaceutical silicon nanoparticle preparations for controlled release and transfection of nucleic acids; pharmaceutical porous silicon nanoparticle preparations for controlled release and transfection of nucleic acids; lipid nanoparticle materials being pharmaceutical preparations for controlled release and transfection of nucleic acids; silicon-lipid nanoparticle materials being pharmaceutical preparations for controlled release and transfection of nucleic acids; silicon-stabilised hybrid lipid nanoparticles being pharmaceutical preparations for controlled release and transfection of nucleic acids; silicon-stabilised lipid nanoparticles being pharmaceutical preparations for controlled release and transfection of nucleic acids; stabilised lipid nanoparticles being pharmaceutical preparations for controlled release and transfection of nucleic acids.

FAQ

About ColHySilic

Who owns the trademark "ColHySilic"?

The WIPO trademark "ColHySilic" is owned by SISAF Ltd.

What is the status of "ColHySilic"?

Its status at the WIPO is: registered.

API

Get this data via the API

Everything on this page comes from the Signa API. Pull ColHySilic and marks like it into your own product with one request.

  • GET/v1/trademarks/{id}

    The full record: owners, classes, dates and images

  • GET/v1/trademarks/{id}/events

    Every step in the office history

  • GET/v1/proceedings?trademark_id={id}

    Oppositions and cancellations against the mark

Get API keyView docs
GET /v1/trademarks/{id}
ID=tm_47f1b46d-9f97-45b5-9573-a3533b529efd
curl https://api.signa.so/v1/trademarks/$ID \
  -H "Authorization: Bearer $SIGNA_API_KEY"
Response
{
  "id": "tm_47f1b46d-9f97-45b5-9573-a3533b529efd",
  "object": "trademark",
  "mark_text": "ColHySilic",
  "status": {
    "primary": "active",
    "stage": "registered"
  },
  "office_code": "WO",
  "application_number": null,
  "filing_date": "2022-05-13",
  "nice_classes": [
    1,
    5
  ],
  "owners": [
    {
      "name": "SISAF Ltd",
      "entity_id": "ent_019eb7e9-8dfe-71b4-9fe2-3a7346d37b08"
    }
  ]
}